What is the difference between an electronic signature and a handwritten signature under FDA 21 CFR Part 11?

Why Part 11 Treats Electronic and Handwritten Signatures Differently

The difference is not just format, it is the control model behind the signature. A handwritten signature is tied to paper and physical custody. An electronic signature under Part 11 has to prove who signed, what they signed, and when, using technical and procedural controls that make the signature trustworthy enough for regulated records.

That distinction matters because the regulator is not asking whether a digital mark looks like a signature, but whether it can reliably support accountability for the record. In practice, the electronic version has to behave like a controlled identity event, not just a typed name or image pasted into a document.

For regulated environments, the key question is whether the signature method creates evidence that can stand up to inspection. Paper signatures rely on physical possession and manual review, while electronic signatures rely on authentication, system controls, and retained evidence that the signing action occurred in a specific context.

What Makes an Electronic Signature Acceptable Under Part 11

An acceptable electronic signature is more than a user clicking “sign.” It must be bound to the signer, tied to the specific record, and supported by controls that reduce the risk of impersonation, repudiation, or tampering. That is why identity proofing, access control, audit trails, and record integrity all matter to the signature itself.

In operational terms, the signer should be uniquely identifiable, the signing event should be time-stamped and preserved, and the system should prevent casual reuse of another person’s credentials. If those elements are weak, the signature may exist visually, but it will not have the trust properties Part 11 expects.

There is also a lifecycle dimension. If a user leaves, changes role, or loses access, the organisation still needs to know that historical signatures remain attributable and that the credentials used for signing were properly governed at the time they were active.

Why the Difference Matters in Validation, Audit, and Record Integrity

Handwritten signatures are often easier to understand in a paper process, but they are harder to validate at scale and do not automatically provide machine-readable evidence. Electronic signatures are stronger for auditability when the system is designed correctly, because the signing event can be logged, linked to the record, and reviewed without depending on a physical document trail.

That same advantage creates an obligation: the organisation has to validate that the signature function actually works as intended. If the signing workflow can be bypassed, shared, or altered after the fact, the form of the signature is irrelevant. The control objective is trustworthy attribution and tamper-evident evidence.

A useful way to think about it is that handwritten signatures prove presence on paper, while compliant electronic signatures prove controlled intent in a system. The latter can be stronger, but only if the surrounding controls preserve authenticity, integrity, and accountability from signing through retention.

Risk and Threat Considerations

The main risk is not that an electronic signature is “less real” than wet ink, but that weak identity controls can make it easier to misuse. If credentials are shared, stolen, or poorly governed, an attacker or insider can create a signature event that appears legitimate while breaking the chain between signer and record.

Failure mechanism: Weak authentication, poor session control, or inadequate audit logging allows a signing action to be attributed to the wrong person or to be disputed later, which undermines the evidentiary value of the record.

Impact: The organisation can lose trust in regulated records, face inspection findings, and have to investigate whether signed records reflect genuine approval or unauthorized activity.

Practitioner Guidance

What to verify: Confirm that the signing workflow uniquely identifies the signer, records the signing event in an audit trail, and preserves the link between the signature and the exact record version being approved. If any one of those three is weak, treat the process as a control gap rather than a usability issue.

What good looks like: Each signed record can be traced to one accountable user, one time of signing, and one immutable audit record, with no shared accounts and no ambiguity about what was approved.

Practitioner takeaway: The practical test is whether the signature creates defensible accountability, not whether it resembles wet ink. If you cannot reliably prove signer, record, and event, the process is functionally weaker than a compliant signature should be.

Related resources from NHI Mgmt Group

• Guide: Pharma and GxP Cybersecurity Guide
• 21 CFR Part 11
• How should regulated teams implement electronic records and signatures to satisfy FDA 21 CFR Part 11 requirements?
• Why does FDA 21 CFR Part 11 require audit trails for electronic records and signatures?
• How do access reviews help protect electronic signature workflows?